MS Intermediate MasterClass 11 – Module 1
These courses are for neurologists who are currently prescribing, experienced MS nurses, final year registrars and pharmacists who may be working in a unit that prescribes MS therapies who want to increase or update their knowledge & belong to a network of MSologists. The course will advance understanding of MS through taught sessions and mentorship (a mentor will be appointed for each participant if required).
‘Multiple Sclerosis Intermediate MasterClass 11’ has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 30 category 1 (external) CPD credit(s). Full conditions of approval are listed in our guidelines. 12 External credits may be claimed for an MSc or equivalent activity.
To complete the course delegates must return for module 2 where they will present their inter-module project/audit to the Academy.
The course is fully funded including a travel allowance for clinicians practising in the UK for both modules. There will be a £100 deposit required to secure your place, this will be invoiced to you upon confirmation. This deposit will be refunded within 30 days of you completing both modules of the course. Failure to attend or if you should cancel less than 8 weeks of the course commencement date this will result in the charge of £100.
You can now login with your account to access the MasterClass resources if you've attended module 1.
Were you registered on this course?
Log in to access resources..Login
This activity has been supported by sponsorship from Roche Products Limited, Biogen Idec Limited and Sanofi Genzyme. The sponsors have had no control over the educational content of this activity.
SpeakersProf Gavin Giovannoni
Professor of Neurology, Barts and The London School of Medicine and Dentistry Dr David Paling
Honorary strategic director, MS Academy & consultant neurologist, Sheffield Teaching Hospitals NHS Foundation Trust Dr Leonora Fisniku
Consultant Neurologist, Cambridge University Hospitals NHS Foundation Trust Dr Saúl Reyes
MS Fellow, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts and The London NHS Trust Prof Helen Ford
Clinical professor of neurology, Leeds Teaching Hospitals/University of Leeds Fredi Cavander-Attwood
Policy Manager for Health and Social Care, MS Society David Martin
CEO, MS Trust Dr Agne Straukiene
Consultant neurologist, Torbay and South Devon NHS Foundation Trust Dr Giles Elrington
Consultant Neurologist Rob Sloan
Head of Insights, Shift.ms Dr Miriam Mattoscio
Consultant Neurologist, Queen’s Hospital, Barking Havering and Redbridge University Hospitals Trust Dr Sharmilee Gnanapavan
Consultant Neurologist, Barts Health and Princess Alexandra Hospital NHS Trust Dr Nikos Evangelou
Clinical associate professor in neurology, University of Nottingham Prof David Baker
Professor of Neuroimmonology, Queen Mary University of London Rachel Dorsey-Campbell
Senior lead pharmacist, Neurosciences, imperial college healthcare NHS trust Prof Klaus Schmierer
Professor of Neurology and Consultant Neurologist, The Blizard Institute, Queen Mary University of London & The Royal London Hospital of Barts Health NHS Trust Dr Gerard Davies
Consultant Neurologist, Royal Free London Dr Ming Lim
Consultant Paediatric Neurologist, Evelina London Children’s Hospital
Encouraging excellence, developing leaders, inspiring change
MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.